Accessibility Menu
Numinus Wellness logo

Numinus Wellness(OTC) NUMIF

Market Cap$12.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-95%
5 Year-94%
1 Year+5%
1 Month-1%
$0.04
-7.77%
-0.00Today
Numinus Wellness last closing stock price
MetricPriceDate
Last closeUSD 0.042026-08-27
Numinus Wellness stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.22%USD 0.042026-08-20
1 month-0.5%USD 0.042026-07-28
3 month+71.24%USD 0.022026-05-29
Year to date+33%USD 0.032025-12-31
1 year+5%USD 0.042025-08-27
3 year-71.03%USD 0.142023-08-28
5 year-94.09%USD 0.682021-08-27
Since inception-95.12%USD 0.722020-05-20

Numinus Wellness Financials at a Glance

Market Cap

$12.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-CA$4.47M

Net Income (TTM)

-CA$14.60M

EPS (TTM)

$0.00

P/E Ratio

-0.56

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$0.04

Volume

1,325

Open

$0.03

Previous Close

$0.04

Daily Range

$0.03 - $0.04

52-Week Range

$0.01 - $0.06

Estimated Earnings Date

Jul 31, 2026

NUMIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Numinus Wellness

Numinus Wellness Inc. is dedicated to pioneering and delivering psychedelic-assisted psychotherapy, aiming to reshape the mental healthcare landscape. The company operates through two primary divisions: Salvation Botanicals and Numinus Health, focusing on innovative therapeutic solutions and comprehensive laboratory services.

Products and Services
  • Salvation Botanicals offers laboratory services for psychedelics and cannabis products
  • Numinus Health provides psychotherapy, counselling, and neurofeedback therapies
  • Training and operational resources for practitioners in mental health and substance abuse
Growth Outlook
  • Increasing demand for mental health solutions drives market potential
  • Expansion of psychedelic therapy research supports innovative treatment options
  • Strategic partnerships enhance service offerings and market reach
Financial Highlights
  • Recent quarterly revenue of CAD 1,802,942 shows growth from previous quarters
  • Gross profit margin improved to 48.26% in the latest quarter
  • Cash and cash equivalents increased to CAD 822,835, indicating liquidity
Numinus Wellness Inc. is positioned at the forefront of a rapidly evolving sector, focusing on mental health solutions through innovative therapies. The company's dual approach, combining laboratory services with therapeutic practices, allows for a comprehensive offering that addresses the growing need for effective mental health care. Recent financial performance indicates a positive trajectory, with increasing revenue and improved gross profit margins. The strategic focus on partnerships and research further enhances the potential for growth in this emerging market. As the demand for mental health solutions continues to rise, Numinus Wellness Inc. stands to play a significant role in shaping the future of mental healthcare.
AI Generated • Aug 22, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

35

CEO

Michael Tan, MBA

Website

numinus.com

Headquarters

Vancouver, BC V6B 3M1, CA

NUMIF Financials

Key Financial Metrics (TTM)

Gross Margin

41.47%

Operating Margin

-75.23%

Net Income Margin

-297.88%

Return on Equity

833.04%

Return on Capital

-424.36%

Return on Assets

-230.35%

Earnings Yield

-1.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

320.55M

Volume

1.32K

Avg. Volume

105.50K

Financials (TTM)

Gross Profit

-CA$820.00K

Operating Income

-CA$23.21M

EBITDA

-CA$11.32M

Operating Cash Flow

-CA$9.59M

Capital Expenditure

-CA$154.18K

Free Cash Flow

-CA$9.75M

Cash & ST Invst.

CA$822.84K

Total Debt

CA$2.32M

Numinus Wellness Performance Analysis

Numinus Wellness annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-08-31CAD 1,192,541N/A
20222022-08-31CAD 5,105,143328.1%
20232023-08-31CAD 2,786,678-45.4%
20242024-08-31CAD 3,063,4319.9%
Numinus Wellness sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-08-31-325.4%
Q12024-11-30120.5%
Q22025-02-28-24.9%
Q32025-05-3119.2%
Numinus Wellness annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-08-31CAD -0.09N/A
20222022-08-31CAD -0.1681.6%
20232023-08-31CAD -0.09-47.7%
20242024-08-31CAD -0.05-42.6%
Numinus Wellness sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-08-3144.9%
Q12024-11-3065.5%
Q22025-02-28-680.5%
Q32025-05-3192.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

CA$1.80M

-58.5%

Gross Profit

CA$870.10K

-9.2%

Gross Margin

48.26%

N/A

Market Cap

$12.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$63.95K

N/A

Employees

200

N/A

Net Income

-CA$711.19K

+87.6%

EBITDA

-CA$601.02K

+86.8%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

CA$822.84K

-77.8%

Total Debt

CA$2.32M

-67.2%

Accounts Receivable

CA$1.42M

-16.9%

Inventory

CA$0.00

N/A

Long Term Debt

CA$1.73M

-60.7%

Short Term Debt

CA$589.42K

-77.8%

Return on Assets

-2.30%

N/A

Return on Invested Capital

-13.89%

N/A

Free Cash Flow

CA$392.99K

+111.3%

Operating Cash Flow

CA$390.09K

+111.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PBSVPharma-Bio Serv, Inc.
$0.54+0.00%
VPTDFVentriPoint Diagnostics Ltd.
$0.07-1.79%
ALRTFALR Technologies Inc.
$0.02+0.00%
FPCGAvem Health Partners, Inc.
$1,025.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$225.49-0.01%
BITOProShares Trust - ProShares Bitcoin ETF
$10.70-0.01%
INTCIntel
$92.57+0.01%
QNRXQuoin Pharmaceuticals
$6.74+0.31%

Questions About NUMIF

What is the current price of Numinus Wellness?

Numinus Wellness is trading at $0.04 per share.

What is the 52-week range for Numinus Wellness?

Over the past 52 weeks, Numinus Wellness has traded between $0.01 and $0.06.

How much debt does Numinus Wellness have?

As of the most recent reporting period, Numinus Wellness reported total debt of CA$1.69M.

How much cash does Numinus Wellness have on hand?

Numinus Wellness reported CA$598.45K in cash and cash equivalents in its most recent financial results.

What is Numinus Wellness’s dividend yield?

Numinus Wellness does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services